doi: 10.3389/fpls.2024.1373801 Received 20 January 2024 Accepted 23 February 2024 Published 12 March 2024 Volume 15 - 2024 Edited by Ahmed Abdelkhalek, City of Scientific Research and Technological Applications, Egypt Reviewed by Nuria Montes, Hospital Universitario de La Princesa, Spain Updates Copyright 2024 Kozie, Otulak-Kozie and Rusin
the safety profile assembled across the six trials remained intact
Optimizing blood pressure, lowering LDL cholesterol, eating well, and staying active remain essential
Underlying health conditionssuch as insulin resistance, type 2 diabetes, PCOS, menopause-related hormonal changes, or the use of certain medicationscan also affect how quickly and how much weight changes over time
The Three Patent Cliff Waves: The US market $20+ billion in annual GLP-1 sales and counting stays protected until at least 2031